ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer.
Nelson RangelIris Lorena SánchezDuván Sebastián ValbuenaMilena Rondón-LagosPublished in: Breast cancer (Dove Medical Press) (2024)
gene in treatment response, together with prospective studies in BC patients, could contribute to confirming our data, as well as optimizing existing treatments and exploring novel approaches to improve overall cancer treatment outcomes.
Keyphrases
- copy number
- mitochondrial dna
- genome wide
- end stage renal disease
- dna methylation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- papillary thyroid
- electronic health record
- squamous cell carcinoma
- peritoneal dialysis
- prognostic factors
- stem cells
- mesenchymal stem cells
- estrogen receptor
- young adults
- squamous cell
- transcription factor
- childhood cancer
- lymph node metastasis
- cell therapy